Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, December 23, 2019
Compounded drugs can serve an important role in meeting patients’ medical needs that cannot be met by an FDA-approved drug.
read more
Monday, December 30, 2019
Sosei Group has been notified by its strategic alliance partner Pfizer that it has nominated a third clinical candidate from the multi-target drug discovery collaboration between the two companies.
read more
Monday, December 30, 2019
Acceleron and Fulcrum have entered into a collaboration and license agreement to identify small molecules designed to modulate specific pathways associated with a targeted indication within the pulmonary disease space.
read more
Monday, December 30, 2019
Dr. Reddy’s announced the launch of Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial, the therapeutic generic equivalent of Nitropress® Injection.
read more
Monday, December 30, 2019
Gilead Sciences and Eisai announced the two companies have entered into an agreement for the distribution and co-promotion of filgotinib, pending regulatory approval for rheumatoid arthritis.
read more
Thursday, January 02, 2020
Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs has received FDA approval for their generic version of Febuxostat 40mg and 80mg tablets.
read more
Thursday, January 02, 2020
MediWound announced the signing of a distribution agreement granting Balance Medical the exclusive rights to market and distribute NexoBrid® in Australia, New Zealand and Singapore for the treatment of severe burns.
read more
Thursday, January 02, 2020
Arena Pharmaceuticals and Beacon Discovery have entered into a strategic multi-year partnership aimed at building novel medicines across a range of GPCR targets.
read more
Pulmatrix has entered into a licensing and development agreement with the Lung Cancer Initiative at Johnson & Johnson.
read more
WuXi STA announced the opening of its large-scale oligonucleotide API manufacturing facility in Changzhou, China.
read more
Wednesday, January 08, 2020
Alcami announced the sale of its preclinical and early stage active pharmaceutical ingredient facility in Weert, Netherlands to MercachemSyncom.
read more
Wednesday, January 08, 2020
Sirnaomics and Innovent Biologics announced they have entered a strategic collaboration to conduct clinical studies, using STP705 and Tyvyt.
read more
Tuesday, January 14, 2020
Tauriga Sciences announced plans to commence development of a pharmaceutical grade version of Tauri-Gum.
read more
Wednesday, January 15, 2020
Dermavant Sciences has entered into a collaboration and license agreement with Japan Tobacco for exclusive rights to develop, register and market tapinarof in Japan for psoriasis and atopic dermatitis.
read more
Wednesday, January 15, 2020
Mereo BioPharma announced a global license agreement for the development and commercialization of navicixizumab.
read more